共 164 条
[1]
Schweitzer A(2015)Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 Lancet (Lond Engl) 386 1546-1555
[2]
Horn J(1996)Global status of hepatitis B immunisation Lancet (Lond Engl) 348 696-504
[3]
Mikolajczyk RT(2010)Management of chronic hepatitis B in pregnancy Clin Liver Dis 14 495-1843
[4]
Krause G(1987)Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection Gastroenterology 92 1839-1457
[5]
Ott JJ(2007)Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F Gastroenterology 133 1452-333
[6]
Kane MA(2016)Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis Hepatology 63 319-103
[7]
Buchanan C(2009)Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study J Viral Hepat 16 94-2334
[8]
Tran TT(2016)Tenofovir to prevent hepatitis B transmission in mothers with high viral load N Engl J Med 374 2324-923
[9]
Lok AS(2018)Tenofovir versus placebo to prevent perinatal transmission of hepatitis B N Engl J Med 378 911-476
[10]
Lai CL(2014)Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice Hepatology 60 468-252